A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Recruiting · NCT07282353 · Registry updated 2026-07-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bile duct disorder, biliary tract disorder, cholestasis, cirrhosis of liver, intrahepatic cholestasis, liver disorder, primary biliary cholangitis | Recruiting | Phase 3 | 2026-07-08 | NCT07282353 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cascade Pharmaceuticals, Inc | 6 |
42 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.